Track topics on Twitter Track topics that are important to you
WEST PALM BEACH, Fla., Aug. 11, 2015 (GLOBE NEWSWIRE) -- Alliance BioEnergy Plus, Inc. (OTCQB:ALLM) (the "Company") announced today the completion of FEL 1, the first of four engineering stages that are required to complete construction of the first commercial CTS plant to be located in central Georgia and expected to break ground this fall.
Working together with Process Engineering Associates, LLC in Alabama and DCR Engineering Services of Tampa, Fl the Company completed this first critical phase weeks ahead of schedule and under budget, which allowed the team to proceed immediately with FEL 2 and start focusing more on the site-specific components of the process.
The engineering process for building a plant, that can convert a 1,000 mt a day of cellulose biomass, using the CTS patented system is a four-stage process; Front-End-Loading known as FEL 1 thru 3 and Detail. FEL 1, which is now complete, focused on magnitude. This includes the general layout of the plant, project scope, design and execution strategy, as well as capacity, raw material handling and storage needs. FEL 1 also started to look at major equipment size and sources, local civil engineering requirements and local utilities and infrastructure. FEL 2, which is now underway, starts to get much more specific on these and many other components of the build including; site specific needs, PFD’s with heat and material balances as well as product purity, piping and electrical layouts. FEL 2 is expected to be complete in early Q4 2015.
The Company anticipates that its central Georgia licensee, RRDA, will break ground on the first commercial plant in the 4th quarter of 2015 and be ready for operations sometime in early summer of 2016. “We are extremely pleased with the progress of the plant engineering and how well this team works together.” Said Jim Brown, President of the Company's subsidiary AMG Energy Group who is tasked with overseeing this project. He went on to say, “We are ahead of schedule, under budget and the scientific team under Dr. Blair really has a grasp on the science, which has made this entire process so much simpler, what else can you ask for.”
Once the critical Process Engineering (FEL 1 & 2) is complete in Q4 2015 and the focus turns to local site prep the Company can start to collect on its signed $25 million territory license agreement and would expect to start collecting royalties form multiple licensees by mid summer 2016.
About ALLM :
Alliance BioEnergy +, Inc. (“ALLM”) (OTCQB:ALLM), is a publicly traded company focusing on “Green” energy and renewable technologies. ALLM’s subsidiaries focus on emerging technologies in the renewable energy, bio-fuels and new technologies sectors. ALLM owns a fifty percent interest in Carbolosic, LLC, and the exclusive rights to North America (including Canada, U.S. and Mexico) and Africa. Carbolosic holds the exclusive, worldwide license to the patented mechanical/chemical technology, “CTS™” developed by the University of Central Florida. The CTS technology is able to produce Sugars, Various Fine Chemicals, Plastics, Carbon Fibers and other valuable products from virtually any plant material, wood or paper by product, fruit casings or bio waste.
Information in this document constitute forward-looking statements or statements which may be deemed or construed to be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The words "forecast", "anticipate", "estimate", "project", "intend", "expect", "should", "believe", and similar expressions are intended to identify forward-looking statements. These forward-looking statements involve, and are subject to known and unknown risks, uncertainties and other factors which could cause Alliance BioEnergy Plus, Inc actual results, performance (financial or operating) or achievements to differ from the future results, performance (financial or operating) or achievements expressed or implied by such forward-looking statements. The risks, uncertainties and other factors are more fully discussed in Alliance Media Group Holdings, Inc filings with the U.S. Securities and Exchange Commission. All forward-looking statements attributable to Alliance BioEnergy Plus, Inc herein are expressly qualified in their entirety by the above-mentioned cautionary statement. Alliance BioEnergy Plus, Inc disclaims any obligation to update forward-looking statements contained in this estimate, except as may be required by law.
Public Relations and Media Contact: LCG Headquarter Office 702.761.6976 www.lcginfo.comNEXT ARTICLE
Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...
Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...
Alliances, mergers acquisitions and partnerships
BioPortfolio's alliances, mergers acquisitions and partnerships channel provides the latest news and corporate information on the global bio-pharmaceutical industry.